Health at a Glance 2019

@article{Farmacoterapia2019HealthAA,
  title={Health at a Glance 2019},
  author={Revista Farmacoterapia},
  journal={Health at a Glance},
  year={2019}
}
The Organization for Economic Cooperation and Development published in November the document «Health at a Glance 2019: OECD Indicators». We publish below data from this report on the pharmaceutical sector, highlighting the numbers for Portugal. Available from: https://www.oecd-ilibrary.org/social-issues-migration-health/health-at-a-glance-2019_4dd50c09-en. 

Social Accountability and Regional Health Priorities in Medical Education.

TLDR
While the basic science and introductory clinical material covered early in medical school is necessary, the data suggest that emphasizing the implications of this foundational curricula for addressing the regions' health priorities is worthy of greater consideration.

How to evaluate the capacity of hospital systems in a very long term international comparative perspective? Hospital beds per inhabitant in Catalonia 1900s-2010s

This article proposes that the number of hospital beds available in a territory can be used as a comparative tool to gain a perspective on the very long term evolution of the historical capacity of

Mental Health Patient-Reported Outcomes and Experiences Assessment in Portugal

TLDR
This study shows the feasibility of implementing and using patient-reported metrics (PROM and PREM) in mental health services in Portugal and generates useful clinical information to help meet the expectations and needs of patients, contributing to a continuous improvement of mental health community services.

The Health Impact Fund: making the case for engagement with pharmaceutical laboratories in Brazil, Russia, India, and China

TLDR
Limits to a BRIC country partnership include lower levels of drug development expertise compared to their high-income pharmaceutical counterparts, and whether the Health Impact Fund and the participating stakeholders have the financial capability to assist in bringing a new drug to market.

Comment on: “The Italian NHS: What Lessons to Draw from COVID-19?”

TLDR
The commentary by Garattini and colleagues on the lessons that the Italian National Health Service (INHS) should learn from COVID-19 and some additional suggestions for discussion are offered, stressing two concepts: balance between technical and political governance, and INHS funding.

The welfare state in really hard times: Political trust and satisfaction with the German healthcare system during the COVID-19 pandemic

TLDR
Strong evidence is found for a positive and robust association between generalized political trust and performance perceptions regarding the efficiency and fairness of the crisis response as well as individual treatment conditions.

Self-Declared Roma Ethnicity and Health Insurance Expenditures: A Nationwide Cross-Sectional Investigation at the General Medical Practice Level in Hungary

TLDR
Lower education, employment, and small practice size were associated with lower NHIF expenditures in Hungary, while the share of self-reported Roma did not significantly affect health expenditures according to the GMP level study.

Is the pandemic management response related to official populism? Lessons learned from COVID-19 so far

The COVID-19 pandemic has served the authoritarian governments and politicians that have proliferated in recent years. Although several of them initially did not believe in its seriousness, now it

How the COVID-19 pandemic affects transgender health care - A cross-sectional online survey in 63 upper-middle-income and high-income countries

TLDR
This project aims to provide real-time information about how to identify and treat the most vulnerable members of the population and provide support for them in the event of their removal from the country.
...